Radiotherapy and hyperbaric oxygen in head and... (1977 study) Skip to main content
Prospective Study Lancet (London, England) 1977

Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial.

Henk JM, Kunkler PB, Smith CW, Lancet (London, England), 1977

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers randomly assigned head and neck cancer patients to receive radiotherapy either while breathing oxygen in a hyperbaric chamber or while breathing air.

What They Found

In a prospective randomized controlled trial of radiotherapy for head and neck cancer, hyperbaric oxygen was linked to significantly better local tumour control than air, but survival did not differ between the two groups. Both groups got identical radiotherapy: 3500 rads in 10 fractions over 3 weeks. The better local control was seen particularly in smaller lesions. The air group had a significantly greater need for salvage surgery. Radiation effects on normal tissue appeared somewhat greater in the oxygen group, especially on laryngeal cartilage.

What This Means for Canadian Patients

For people with head and neck cancer, this trial found better local tumour control when radiotherapy was given in hyperbaric oxygen, but no difference in survival. It also reported somewhat greater radiation effects on normal tissue in the oxygen group, especially laryngeal cartilage. Anyone considering this approach should talk with their cancer care team about these benefits and risks.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract does not report the number of patients, the oxygen pressure used, or exact statistics, and the radiotherapy schedule it describes (3500 rads in 10 fractions) comes from a 1977 trial, so it may differ from current practice.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Prospective Study
Category Radiation Injury
Source Pubmed
PubMed ID 69191
Year Published 1977
Journal Lancet (London, England)
MeSH Terms Carcinoma, Squamous Cell; Clinical Trials as Topic; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Laryngeal Neoplasms; Male; Mouth Neoplasms; Neoplasm Recurrence, Local; Nose Neoplasms; Pharyngeal Neoplasms; Prospective Studies; Radiotherapy Dosage

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology